HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention
- PMID: 17694074
- DOI: 10.1038/sj.onc.1210599
HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention
Abstract
Acetylation of the epsilon-amino group of a lysine residue was first discovered with histones in 1968, but the responsible enzymes, histone acetyltransferases and deacetylases, were not identified until the mid-1990s. In the past decade, knowledge about this modification has exploded, with targets rapidly expanding from histones to transcription factors and other nuclear proteins, and then to cytoskeleton, metabolic enzymes, and signaling regulators in the cytoplasm. Thus, protein lysine acetylation has emerged as a major post-translational modification to rival phosphorylation. In this issue of Oncogene, 19 articles review various aspects of the enzymes governing lysine acetylation, especially about their intimate links to cancer. To introduce the articles, we highlight here four central themes: (i) multisubunit enzymatic complexes; (ii) non-histone substrates in diverse cellular processes; (iii) interplay of lysine acetylation with other regulatory mechanisms, such as noncoding RNA-mediated gene silencing and activation; and (iv) novel therapeutic strategies and preventive measures to combat cancer and other human diseases.
Similar articles
-
Regulation of protein turnover by acetyltransferases and deacetylases.Biochimie. 2008 Feb;90(2):306-12. doi: 10.1016/j.biochi.2007.06.009. Epub 2007 Jul 1. Biochimie. 2008. PMID: 17681659 Review.
-
Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.Oncogene. 2007 Aug 13;26(37):5528-40. doi: 10.1038/sj.onc.1210619. Oncogene. 2007. PMID: 17694092 Review.
-
Acetylation of proteins as novel target for antitumor therapy: review article.Amino Acids. 2004 Jul;26(4):435-41. doi: 10.1007/s00726-004-0087-3. Epub 2004 Jun 11. Amino Acids. 2004. PMID: 15290351 Review.
-
Acetylation of non-histone proteins modulates cellular signalling at multiple levels.Int J Biochem Cell Biol. 2009 Jan;41(1):185-98. doi: 10.1016/j.biocel.2008.08.027. Epub 2008 Sep 2. Int J Biochem Cell Biol. 2009. PMID: 18804549 Review.
-
Small molecule modulators in epigenetics: implications in gene expression and therapeutics.Subcell Biochem. 2007;41:397-428. Subcell Biochem. 2007. PMID: 17484138 Review.
Cited by
-
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease.Age (Dordr). 2013 Jun;35(3):519-31. doi: 10.1007/s11357-011-9375-5. Epub 2012 Jan 12. Age (Dordr). 2013. PMID: 22237558 Free PMC article.
-
Role of Epigenetics for the Efficacy of Cisplatin.Int J Mol Sci. 2024 Jan 17;25(2):1130. doi: 10.3390/ijms25021130. Int J Mol Sci. 2024. PMID: 38256203 Free PMC article. Review.
-
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.Leukemia. 2012 Jun;26(6):1356-64. doi: 10.1038/leu.2011.340. Epub 2011 Nov 25. Leukemia. 2012. PMID: 22116549 Free PMC article.
-
Advances in the Regulation of Mammalian Follicle-Stimulating Hormone Secretion.Animals (Basel). 2021 Apr 15;11(4):1134. doi: 10.3390/ani11041134. Animals (Basel). 2021. PMID: 33921032 Free PMC article. Review.
-
A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.Neurotox Res. 2016 Oct;30(3):510-20. doi: 10.1007/s12640-016-9636-2. Epub 2016 Jun 2. Neurotox Res. 2016. PMID: 27256286
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous